Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity

Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) where the communication ability of nerve cells in the brain and spinal cord with each other gets impaired. Some current findings suggest the role of glutamate excitotoxicity in the development and progr...

Full description

Saved in:
Bibliographic Details
Main Authors: Ankit A. Gilani, Ranjeet Prasad Dash, Mehul N. Jivrajani, Sandeep Kumar Thakur, Manish Nivsarkar
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Advances in Pharmacological Sciences
Online Access:http://dx.doi.org/10.1155/2014/632376
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554318034632704
author Ankit A. Gilani
Ranjeet Prasad Dash
Mehul N. Jivrajani
Sandeep Kumar Thakur
Manish Nivsarkar
author_facet Ankit A. Gilani
Ranjeet Prasad Dash
Mehul N. Jivrajani
Sandeep Kumar Thakur
Manish Nivsarkar
author_sort Ankit A. Gilani
collection DOAJ
description Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) where the communication ability of nerve cells in the brain and spinal cord with each other gets impaired. Some current findings suggest the role of glutamate excitotoxicity in the development and progression of MS. An excess release of glutamate leads to the activation of ionotropic and metabotropic receptors, thus resulting in accumulation of toxic cytoplasmic Ca2+ and cell death. However, it has been observed that gamma-aminobutyric acid-A (GABAA) receptors located in the nerve terminals activate presynaptic Ca2+/calmodulin-dependent signaling to inhibit depolarization-evoked Ca2+ influx and glutamate release from isolated nerve terminals, which suggest a potential implication of GABAA receptor in management of MS. With this proof of concept, we tried to explore the potential of selective GABAA receptor agonists or positive allosteric modulators (diazepam and phenobarbitone sodium) and GABAA level enhancer (sodium valproate) for management of MS by screening them for their activity in experimental autoimmune encephalomyelitis (EAE) model in rats and cuprizone-induced demyelination model in mice. In this study, sodium valproate was found to show the best activity in the animal models whereas phenobarbitone sodium showed moderate activity. However, diazepam was found to be ineffective.
format Article
id doaj-art-cfe7564ab1a04955a4bfaa9256f19e29
institution Kabale University
issn 1687-6334
1687-6342
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological Sciences
spelling doaj-art-cfe7564ab1a04955a4bfaa9256f19e292025-02-03T05:51:51ZengWileyAdvances in Pharmacological Sciences1687-63341687-63422014-01-01201410.1155/2014/632376632376Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated ExcitotoxicityAnkit A. Gilani0Ranjeet Prasad Dash1Mehul N. Jivrajani2Sandeep Kumar Thakur3Manish Nivsarkar4Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, C/O-B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, IndiaDepartment of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, IndiaDepartment of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, IndiaDepartment of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, IndiaDepartment of Pharmacology and Toxicology, B. V. Patel Pharmaceutical Education and Research Development (PERD) Centre, S. G. Highway, Thaltej, Ahmedabad, Gujarat 380054, IndiaMultiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) where the communication ability of nerve cells in the brain and spinal cord with each other gets impaired. Some current findings suggest the role of glutamate excitotoxicity in the development and progression of MS. An excess release of glutamate leads to the activation of ionotropic and metabotropic receptors, thus resulting in accumulation of toxic cytoplasmic Ca2+ and cell death. However, it has been observed that gamma-aminobutyric acid-A (GABAA) receptors located in the nerve terminals activate presynaptic Ca2+/calmodulin-dependent signaling to inhibit depolarization-evoked Ca2+ influx and glutamate release from isolated nerve terminals, which suggest a potential implication of GABAA receptor in management of MS. With this proof of concept, we tried to explore the potential of selective GABAA receptor agonists or positive allosteric modulators (diazepam and phenobarbitone sodium) and GABAA level enhancer (sodium valproate) for management of MS by screening them for their activity in experimental autoimmune encephalomyelitis (EAE) model in rats and cuprizone-induced demyelination model in mice. In this study, sodium valproate was found to show the best activity in the animal models whereas phenobarbitone sodium showed moderate activity. However, diazepam was found to be ineffective.http://dx.doi.org/10.1155/2014/632376
spellingShingle Ankit A. Gilani
Ranjeet Prasad Dash
Mehul N. Jivrajani
Sandeep Kumar Thakur
Manish Nivsarkar
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
Advances in Pharmacological Sciences
title Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
title_full Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
title_fullStr Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
title_full_unstemmed Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
title_short Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity
title_sort evaluation of gabaergic transmission modulation as a novel functional target for management of multiple sclerosis exploring inhibitory effect of gaba on glutamate mediated excitotoxicity
url http://dx.doi.org/10.1155/2014/632376
work_keys_str_mv AT ankitagilani evaluationofgabaergictransmissionmodulationasanovelfunctionaltargetformanagementofmultiplesclerosisexploringinhibitoryeffectofgabaonglutamatemediatedexcitotoxicity
AT ranjeetprasaddash evaluationofgabaergictransmissionmodulationasanovelfunctionaltargetformanagementofmultiplesclerosisexploringinhibitoryeffectofgabaonglutamatemediatedexcitotoxicity
AT mehulnjivrajani evaluationofgabaergictransmissionmodulationasanovelfunctionaltargetformanagementofmultiplesclerosisexploringinhibitoryeffectofgabaonglutamatemediatedexcitotoxicity
AT sandeepkumarthakur evaluationofgabaergictransmissionmodulationasanovelfunctionaltargetformanagementofmultiplesclerosisexploringinhibitoryeffectofgabaonglutamatemediatedexcitotoxicity
AT manishnivsarkar evaluationofgabaergictransmissionmodulationasanovelfunctionaltargetformanagementofmultiplesclerosisexploringinhibitoryeffectofgabaonglutamatemediatedexcitotoxicity